Convexia

StagePre-seed
Founded2025
Team size1-10
IndustriesBiotechnology

About Convexia

Convexia is an AI-native platform that finds and evaluates overlooked drug assets faster than anyone else. It combines automated sourcing, in silico modeling, and commercial analysis to identify high-potential molecules and package them for future buyers. Convexia aims to replace months of manual diligence with an integrated agent stack, turning hidden assets into ready-to-license opportunities, end-to-end. Convexia positions itself in the market as faster than anyone else at finding and evaluating overlooked drug assets.

Open positions · 1

Company at a glance

Locations
Los Angeles, United States ·New York City, United States ·United States ·San Francisco, United States
LinkedInLinkedIn

Founders & Leadership

AP

Ayaan Parikh

Co-Founder @ Convexia (YC S25) | Stanford CS + Bio

LinkedIn
RV

Rahul Vijayan

Co-Founder @ Convexia (YC S25) | Stanford CS + Econ

LinkedIn

Location

About the Team

Team Distribution

  • Leadership67%
  • Software Engineering33%

Where the Team Studied

  1. 1.Stanford University
  2. 2.Queens College

Team Worked At

  • Cold Spring Harbor Laboratory

Team Composition

3 people
  • Entrepreneurship2 senior2

Frequently asked questions

Companies similar to Convexia

EVANIUM

EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.

Biotechnology1-10
Aira

Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.

HealthTech1-10
Ambra

Founded by Ayla, a former healthcare investor and EMT, and August, a founding engineer with deep expertise in voice and AI healthcare, this San Francisco-based company is transforming emergency medical services billing and claims. Backed by Eniac and Euclid Ventures at the pre-seed stage, the company is already live with customers and approaching $1M in annual recurring revenue. The lean, two-person founding team is deliberately building a small, elite organization focused on solving critical pain points in the EMS industry. With founders who combine both operational healthcare experience and technical sophistication, the company is positioned to bring much-needed innovation to a traditionally fragmented and inefficient market.

HealthTech1-10